27 employees
VBL Therapeutics is an innovative and diversified, clinical stage biotechnology company
2000
$28M
from 1 investors over 1 rounds
Vascular Biogenics Ltd. (also known as VBL Therapeutics) raised $28M on April 1, 2021
Investors: ROTH Capital Partners